BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 25169057)

  • 1. Plasma lipidomics discloses metabolic syndrome with a specific HDL phenotype.
    Jové M; Naudí A; Portero-Otin M; Cabré R; Rovira-Llopis S; Bañuls C; Rocha M; Hernández-Mijares A; Victor VM; Pamplona R
    FASEB J; 2014 Dec; 28(12):5163-71. PubMed ID: 25169057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Isoenergetic diets differing in their n-3 fatty acid and polyphenol content reflect different plasma and HDL-fraction lipidomic profiles in subjects at high cardiovascular risk.
    Bondia-Pons I; Pöhö P; Bozzetto L; Vetrani C; Patti L; Aura AM; Annuzzi G; Hyötyläinen T; Rivellese AA; Orešič M
    Mol Nutr Food Res; 2014 Sep; 58(9):1873-82. PubMed ID: 24961394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Usefulness of lipid ratios and atherogenic index of plasma in obese Moroccan women with or without metabolic syndrome.
    Essiarab F; Taki H; Lebrazi H; Sabri M; Saïle R
    Ethn Dis; 2014; 24(2):207-12. PubMed ID: 24804368
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome in Mediterranean women with polycystic ovary syndrome: when and how to predict its onset.
    Espinós-Gómez JJ; Rodriguez-Espinosa J; Ordóñez-Llanos J; Calaf-Alsina J
    Gynecol Endocrinol; 2012 Apr; 28(4):264-8. PubMed ID: 21962027
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of anthropometric, metabolic and dietary fatty acids profiles in lean and obese dyslipidaemic Asian Indian male subjects.
    Ghosh A
    Eur J Clin Nutr; 2007 Mar; 61(3):412-9. PubMed ID: 17006446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The association of non-HDL cholesterol with the presence of metabolic syndrome in North Indian subjects with and without CAD.
    Garg PR; Kabita S; Sinha E; Kalla L; Kaur L; Saraswathy KN
    Ann Hum Biol; 2013 Jan; 40(1):111-5. PubMed ID: 23198906
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of assessment techniques: plasma lipid and lipoproteins related to the metabolic syndrome.
    Davy BM; Davy KP
    Lipids Health Dis; 2006 Jan; 5():3. PubMed ID: 16448573
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between plasma HDL subclasses distribution and lipoprotein lipase gene HindIII polymorphism in hyperlipidemia.
    Long S; Tian Y; Zhang R; Yang L; Xu Y; Jia L; Fu M
    Clin Chim Acta; 2006 Apr; 366(1-2):316-21. PubMed ID: 16364275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anthropometric, metabolic and dietary fatty acids profiles in lean and obese diabetic Asian Indian subjects.
    Ghosh A
    Asia Pac J Clin Nutr; 2006; 15(2):189-95. PubMed ID: 16672202
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater impairment of postprandial triacylglycerol than glucose response in metabolic syndrome subjects with fasting hyperglycaemia.
    Jackson KG; Walden CM; Murray P; Smith AM; Minihane AM; Lovegrove JA; Williams CM
    Metabolism; 2013 Aug; 62(8):1065-9. PubMed ID: 23598085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fatty acid composition, estimated desaturase activities, and their relation with the metabolic syndrome in a population at high risk of cardiovascular disease.
    Mayneris-Perxachs J; Guerendiain M; Castellote AI; Estruch R; Covas MI; Fitó M; Salas-Salvadó J; Martínez-González MA; Aros F; Lamuela-Raventós RM; López-Sabater MC;
    Clin Nutr; 2014 Feb; 33(1):90-7. PubMed ID: 23591154
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identifying cardiovascular disease risk and outcome: use of the plasma triglyceride/high-density lipoprotein cholesterol concentration ratio versus metabolic syndrome criteria.
    Salazar MR; Carbajal HA; Espeche WG; Aizpurúa M; Leiva Sisnieguez CE; March CE; Balbín E; Stavile RN; Reaven GM
    J Intern Med; 2013 Jun; 273(6):595-601. PubMed ID: 23331522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of obesity and metabolic syndrome on plasma oxysterols and fatty acids in human.
    Tremblay-Franco M; Zerbinati C; Pacelli A; Palmaccio G; Lubrano C; Ducheix S; Guillou H; Iuliano L
    Steroids; 2015 Jul; 99(Pt B):287-92. PubMed ID: 25896943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of low-density lipoprotein and high-density lipoprotein subclasses in patients with sarcoidosis.
    Vekic J; Zeljkovic A; Jelic-Ivanovic Z; Spasojevic-Kalimanovska V; Spasic S; Videnovic-Ivanov J; Ivanisevic J; Vucinic-Mihailovic V; Gojkovic T
    Arch Pathol Lab Med; 2013 Dec; 137(12):1780-7. PubMed ID: 24283859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between plasma lipid concentrations and HDL subclasses.
    Yang Y; Yan B; Fu M; Xu Y; Tian Y
    Clin Chim Acta; 2005 Apr; 354(1-2):49-58. PubMed ID: 15748599
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spectrum of lipid and lipoprotein indices in human subjects with insulin resistance syndrome.
    Khan SH; Khan FA; Ijaz A; Sattar A; Dilawar M; Hashim R
    J Ayub Med Coll Abbottabad; 2008; 20(3):17-22. PubMed ID: 19610507
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring the lipoprotein composition using Bayesian regression on serum lipidomic profiles.
    Sysi-Aho M; Vehtari A; Velagapudi VR; Westerbacka J; Yetukuri L; Bergholm R; Taskinen MR; Yki-Järvinen H; Oresic M
    Bioinformatics; 2007 Jul; 23(13):i519-28. PubMed ID: 17646339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age, abdominal obesity, and baseline high-sensitivity C-reactive protein are associated with low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B responses to ezetimibe/simvastatin and atorvastatin in patients with metabolic syndrome.
    Robinson JG; Ballantyne CM; Hsueh WA; Rosen JB; Lin J; Shah AK; Tomassini JE; Lowe RS; Tershakovec AM
    J Clin Lipidol; 2013; 7(4):292-303. PubMed ID: 23890516
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effects of orlistat and fenofibrate, alone or in combination, on high-density lipoprotein subfractions and pre-beta1-HDL levels in obese patients with metabolic syndrome.
    Filippatos TD; Liberopoulos EN; Kostapanos M; Gazi IF; Papavasiliou EC; Kiortsis DN; Tselepis AD; Elisaf MS
    Diabetes Obes Metab; 2008 Jun; 10(6):476-83. PubMed ID: 17459096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Contribution of serum leptin to metabolic syndrome in obese and nonobese subjects.
    Esteghamati A; Noshad S; Khalilzadeh O; Morteza A; Nazeri A; Meysamie A; Esteghamati A; Nakhjavani M
    Arch Med Res; 2011 Apr; 42(3):244-51. PubMed ID: 21722822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.